Results 211 to 220 of about 1,123,446 (256)
Some of the next articles are maybe not open access.
Type 2 Diabetes Mellitus in China
, 2020Vast changes in demographics, income, and population health have led to an exponential increase in type 2 diabetes mellitus over the past 3 decades in China. This article discusses some type 2 diabetes mellitus risk factors such as genetics, obesity, and
D. Zhu, J. Dwyer, C. Ouyang
semanticscholar +1 more source
Genes and type 2 diabetes mellitus
Current Diabetes Reports, 2008In 2007, five whole genome-wide association studies were published on the genetics of type 2 diabetes mellitus (T2DM), followed by the discovery of 11 genes consistently associated with T2DM. This breakthrough provided the first glimpses of a complete picture of the disease's genetic complexity.
Leif Groop, Valeriya Lyssenko
openaire +3 more sources
The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
Nature reviews: Gastroenterology & hepatology, 2021G. Targher, K. Corey, C. Byrne, M. Roden
semanticscholar +1 more source
Type 2 Diabetes Mellitus in Children
Endocrine Practice, 1998To provide an overview of type 2 diabetes in children and discuss short-term and long-term management strategies.We review the distinction among various types of diabetes mellitus as they apply to children. In addition, we discuss determining the precise diagnosis between the two major variants--type 1 and type 2 diabetes--and clinical management of ...
John H. Pohl+2 more
openaire +3 more sources
Lixisenatide for type 2 diabetes mellitus
Expert Opinion on Investigational Drugs, 2011Type 2 diabetes mellitus (T2DM) is an increasing health problem worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists are an expanding drug class that target several of the pathophysiological traits of T2DM. Lixisenatide is a GLP-1 receptor agonist in development for once-daily treatment of T2DM.Pharmacological, preclinical and clinical evidence
Christensen, Mikkel+3 more
openaire +4 more sources
Type 2 diabetes mellitus in adolescents
Current Opinion in Pediatrics, 2000Type 2 diabetes mellitus, a significant cause of adult morbidity and mortality, is being diagnosed more frequently in children and adolescents. Genetic predisposition and environmental factors are important determinants for the expression of this disease.
M J Mansfield, S T Callahan
openaire +3 more sources
1999
Type 2 diabetes mellitus is a disease characterized by both abnormalities in insulin secretion and target-tissue resistance to the actions of insulin. Therefore, it is not surprising that replacement therapy with insulin alone is not sufficient to control blood glucose and many of the other metabolic abnormalities in patients with type 2 diabetes ...
Rubin Bressler, David Johnson
openaire +2 more sources
Type 2 diabetes mellitus is a disease characterized by both abnormalities in insulin secretion and target-tissue resistance to the actions of insulin. Therefore, it is not surprising that replacement therapy with insulin alone is not sufficient to control blood glucose and many of the other metabolic abnormalities in patients with type 2 diabetes ...
Rubin Bressler, David Johnson
openaire +2 more sources
Type 2 diabetes mellitus in older adults: clinical considerations and management
Nature Reviews Endocrinology, 2021S. Bellary+3 more
semanticscholar +1 more source
Hyperuricaemia and type 2 diabetes mellitus
Clinical and Experimental Pharmacology and Physiology, 2018SummaryChoi et al reported the effect of hyperuricaemia on the new‐onset type 2 diabetes mellitus (T2DM). I present three queries. (i) Insulin is considered to stimulate uric acid reabsorption via specific transporter and the effect of hyperuricaemia on the new‐onset T2DM should be evaluated by considering insulin resistance. (ii) There is a limitation
openaire +2 more sources